Cargando…

The impact of nonosteogenic factors on the expression of osteoprotegerin and RANKL during human fracture healing

OBJECTIVES: The osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-B ligand (RANKL) balance is of the utmost importance in fracture healing. The aim of this study was therefore to investigate the impact of nonosteogenic factors on OPG and RANKL levels. METHODS: Serum obtained from...

Descripción completa

Detalles Bibliográficos
Autores principales: Starlinger, Julia, Kaiser, Georg, Thomas, Anita, Sarahrudi, Kambiz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691367/
https://www.ncbi.nlm.nih.gov/pubmed/31463043
http://dx.doi.org/10.1302/2046-3758.87.BJR-2018-0116.R3
_version_ 1783443365466996736
author Starlinger, Julia
Kaiser, Georg
Thomas, Anita
Sarahrudi, Kambiz
author_facet Starlinger, Julia
Kaiser, Georg
Thomas, Anita
Sarahrudi, Kambiz
author_sort Starlinger, Julia
collection PubMed
description OBJECTIVES: The osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-B ligand (RANKL) balance is of the utmost importance in fracture healing. The aim of this study was therefore to investigate the impact of nonosteogenic factors on OPG and RANKL levels. METHODS: Serum obtained from 51 patients with long bone fractures was collected over 48 weeks. The OPG and serum sRANKL (soluble RANKL) concentrations were measured using enzyme-linked immunosorbent assay (ELISA). Smoking habit, diabetes, and alcohol consumption were recorded. RESULTS: Age and sex greatly influenced preoperative serum levels of OPG and sRANKL but differences were even more pronounced during fracture healing. Statistical significance was observed for overall serum levels of OPG (p = 0.001) and sRANKL (p < 0.001) in older men and women (age greater than 50 years). Interestingly, OPG levels increased over time in older women but decreased over time in older men. CONCLUSION: These data suggest that nonosteogenic factors, most significantly age and sex, have a major impact on sRANKL and OPG levels. Given the established association of OPG and sRANKL levels and nonunion, these findings seem to be of clinical relevance. Cite this article: J. Starlinger, G. Kaiser, A. Thomas, K. Sarahrudi. The impact of nonosteogenic factors on the expression of osteoprotegerin and RANKL during human fracture healing. Bone Joint Res 2019;8:349–356. DOI: 10.1302/2046-3758.87.BJR-2018-0116.R3.
format Online
Article
Text
id pubmed-6691367
institution National Center for Biotechnology Information
language English
publishDate 2019
record_format MEDLINE/PubMed
spelling pubmed-66913672019-08-28 The impact of nonosteogenic factors on the expression of osteoprotegerin and RANKL during human fracture healing Starlinger, Julia Kaiser, Georg Thomas, Anita Sarahrudi, Kambiz Bone Joint Res Bone Fracture OBJECTIVES: The osteoprotegerin (OPG) and receptor activator of nuclear factor kappa-B ligand (RANKL) balance is of the utmost importance in fracture healing. The aim of this study was therefore to investigate the impact of nonosteogenic factors on OPG and RANKL levels. METHODS: Serum obtained from 51 patients with long bone fractures was collected over 48 weeks. The OPG and serum sRANKL (soluble RANKL) concentrations were measured using enzyme-linked immunosorbent assay (ELISA). Smoking habit, diabetes, and alcohol consumption were recorded. RESULTS: Age and sex greatly influenced preoperative serum levels of OPG and sRANKL but differences were even more pronounced during fracture healing. Statistical significance was observed for overall serum levels of OPG (p = 0.001) and sRANKL (p < 0.001) in older men and women (age greater than 50 years). Interestingly, OPG levels increased over time in older women but decreased over time in older men. CONCLUSION: These data suggest that nonosteogenic factors, most significantly age and sex, have a major impact on sRANKL and OPG levels. Given the established association of OPG and sRANKL levels and nonunion, these findings seem to be of clinical relevance. Cite this article: J. Starlinger, G. Kaiser, A. Thomas, K. Sarahrudi. The impact of nonosteogenic factors on the expression of osteoprotegerin and RANKL during human fracture healing. Bone Joint Res 2019;8:349–356. DOI: 10.1302/2046-3758.87.BJR-2018-0116.R3. 2019-08-02 /pmc/articles/PMC6691367/ /pubmed/31463043 http://dx.doi.org/10.1302/2046-3758.87.BJR-2018-0116.R3 Text en © 2019 Author(s) et al. https://creativecommons.org/licenses/by-nc/4.0/ Open Access This article is distributed under the terms of the Creative Commons Attribution-Non Commercial 4.0 International (CC BY-NC 4.0) licence (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed.
spellingShingle Bone Fracture
Starlinger, Julia
Kaiser, Georg
Thomas, Anita
Sarahrudi, Kambiz
The impact of nonosteogenic factors on the expression of osteoprotegerin and RANKL during human fracture healing
title The impact of nonosteogenic factors on the expression of osteoprotegerin and RANKL during human fracture healing
title_full The impact of nonosteogenic factors on the expression of osteoprotegerin and RANKL during human fracture healing
title_fullStr The impact of nonosteogenic factors on the expression of osteoprotegerin and RANKL during human fracture healing
title_full_unstemmed The impact of nonosteogenic factors on the expression of osteoprotegerin and RANKL during human fracture healing
title_short The impact of nonosteogenic factors on the expression of osteoprotegerin and RANKL during human fracture healing
title_sort impact of nonosteogenic factors on the expression of osteoprotegerin and rankl during human fracture healing
topic Bone Fracture
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6691367/
https://www.ncbi.nlm.nih.gov/pubmed/31463043
http://dx.doi.org/10.1302/2046-3758.87.BJR-2018-0116.R3
work_keys_str_mv AT starlingerjulia theimpactofnonosteogenicfactorsontheexpressionofosteoprotegerinandranklduringhumanfracturehealing
AT kaisergeorg theimpactofnonosteogenicfactorsontheexpressionofosteoprotegerinandranklduringhumanfracturehealing
AT thomasanita theimpactofnonosteogenicfactorsontheexpressionofosteoprotegerinandranklduringhumanfracturehealing
AT sarahrudikambiz theimpactofnonosteogenicfactorsontheexpressionofosteoprotegerinandranklduringhumanfracturehealing
AT starlingerjulia impactofnonosteogenicfactorsontheexpressionofosteoprotegerinandranklduringhumanfracturehealing
AT kaisergeorg impactofnonosteogenicfactorsontheexpressionofosteoprotegerinandranklduringhumanfracturehealing
AT thomasanita impactofnonosteogenicfactorsontheexpressionofosteoprotegerinandranklduringhumanfracturehealing
AT sarahrudikambiz impactofnonosteogenicfactorsontheexpressionofosteoprotegerinandranklduringhumanfracturehealing